Jacki Chou, MPP, MPL
Senior Director, Policy & Economics
Ms. Chou has extensive experience in policy-facing research in a diversity of therapeutic areas including oncology, infectious diseases, and psychiatry. She has also worked with interdisciplinary strategic advisory boards and steering committees to explore research gaps and regulatory hurdles in diabetes, cost-effectiveness research, medical devices, and digital medicine. Ms. Chou has expertise in literature-based economic and epidemiological models demonstrating the benefit of innovative treatments to society. As a Senior Director, Ms. Chou manages a team of PHE researchers across a wide variety of disciplines and projects. Ms. Chou has previously worked at the RAND Corporation assisting health policy researchers working on HIV and sex education, childhood obesity, and consumer satisfaction with hospitals. Ms. Chou has additional research experience in food policy, neighborhood councils, homeland security, and small business pensions. She served as the managing editor and the co-editor-in-chief for the University of Southern California’s Policy & Practice Journal.
MPP, MPL, University of Southern California
BA, History of Science, Harvard University
ASSOCIATED CASE STUDIES
- Chou JW, et al. Public-private partnership as a path to affordable healthcare in emerging markets. Forum Health Econ Policy. 2015.
- Jena AB, et al. Value of improved lipid control in patients at high risk for adverse cardiac events. Am J Manag Care. 2016.
- Lakdawalla DN, et al. Evaluating expected costs and benefits of granting access to new treatments on the basis of progression-free survival in non-small-cell lung cancer. JAMA Oncol. 2015.
- Toth PP, et al. Why published studies of the cost-effectiveness of PCSK-9 inhibitors yielded such markedly different results. J Med Econ. 2017.
- Van Nuys K, et al. Broad hepatitis C treatment scenarios return substantial health gains, but capacity is a concern. Health Aff (Millwood). 2015.